article thumbnail

Lung cancer deaths decline but.

World of DTC Marketing

In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. But it’s still the leading cause of cancer deaths. Although lung cancer’s mortality rate has fallen, the disease is still the leading cause of cancer deaths.

Medicine 271
article thumbnail

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The race for a new class of antibiotics

European Pharmaceutical Review

A study on the surge of new antimicrobial research has shown that despite almost a quarter of a million research papers (227,808) being published on the 12 bacterial families in the World Health Organization (WHO) global priority pathogen list of antibiotic-resistant bacteria from 2017, no new class of antibiotics has gone to market since 1987.

article thumbnail

CustomersFirst Now Announces New Release of CFN Insight™ at the Gainsight Pulse 2017 Customer Success Conference

Clarivate

Reports and custom views are two of the most robust features of CFN Insight because they allow users to monitor activities and progress on resolving customer pain points that lead to Customer Success. OAKLAND, Calif. ” says Steven Williams, VP of Product Management at CFN. About CustomersFirst Now. Media Contact. Anthony Sanchez.

Media 40
article thumbnail

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021.

article thumbnail

Clarivate announces the inaugural Eugene Garfield Memorial Lecture

Clarivate

Many of the world’s leading scientometric and science policy researchers gather annually at the STI conference, making it the ideal venue to connect the current work of ISI with the legacy of Dr. Garfield and his indelible impact on the scholarly community.

article thumbnail

New FDA head needs to examine the accelerated approval program

World of DTC Marketing

The analysis focused on Medicare Part B and Part D spending — which covers outpatient medical care and prescription drugs, respectively, — in 2017, 2018 and 2019, the researchers said. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5

FDA 234